These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6650095)

  • 1. [C-reactive protein in the evaluation of the activity of Crohn's disease].
    Gillard C; Brassinne A
    Acta Gastroenterol Belg; 1983; 46(1-2):39-46. PubMed ID: 6650095
    [No Abstract]   [Full Text] [Related]  

  • 2. CT findings and clinical activity in Crohn's disease.
    Minordi LM; Vecchioli A; Guidi L; Poloni G; Fedeli G; Bonomo L
    Clin Imaging; 2009; 33(2):123-9. PubMed ID: 19237055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [C-reactive protein usefulness in diagnosis and survey of Crohn's disease and ulcerative colitis (author's transl)].
    André C; Descos L; André F; Vignal J; Druguet M
    Gastroenterol Clin Biol; 1979 Nov; 3(11):789-94. PubMed ID: 527789
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease.
    Karoui S; Ouerdiane S; Serghini M; Jomni T; Kallel L; Fekih M; Boubaker J; Filali A
    Dig Liver Dis; 2007 Nov; 39(11):1006-10. PubMed ID: 17889628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological measurements of Crohn's disease activity--a reassessment.
    André C; Descos L; André F; Vignal J; Landais P; Fermanian J
    Hepatogastroenterology; 1985 Jun; 32(3):135-7. PubMed ID: 2410345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of C-reactive protein with activity of Crohn's disease].
    Yang CH; Chen XY; Yang F; Ran ZH; Liu WZ; Xiao SD
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1253-5. PubMed ID: 16796884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
    Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK
    Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of beta-2-microglobulin--a new marker of activity in Crohn's disease.
    Descos L; André C; Beorghia S; Vincent C; Revillard JP
    N Engl J Med; 1979 Aug; 301(8):440-1. PubMed ID: 88674
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.
    Andre C; Descos L; Landais P; Fermanian J
    Gut; 1981 Jul; 22(7):571-4. PubMed ID: 6973509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of red cell distribution width for assessing disease activity in Crohn's disease.
    Hu D; Ren J; Wang G; Gu G; Li G; Liu S; Wu X; Chen J; Wu Q; Ren H; Hong Z; Li J
    Am J Med Sci; 2015 Jan; 349(1):42-5. PubMed ID: 25171547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral butyrate for mildly to moderately active Crohn's disease.
    Di Sabatino A; Morera R; Ciccocioppo R; Cazzola P; Gotti S; Tinozzi FP; Tinozzi S; Corazza GR
    Aliment Pharmacol Ther; 2005 Nov; 22(9):789-94. PubMed ID: 16225487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinogen values in the development of active inflammatory diseases of the intestines].
    Petrović M
    Vojnosanit Pregl; 1980; 37(6):454-7. PubMed ID: 7210586
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab prevents Crohn's disease recurrence after ileal resection.
    Regueiro M; Schraut W; Baidoo L; Kip KE; Sepulveda AR; Pesci M; Harrison J; Plevy SE
    Gastroenterology; 2009 Feb; 136(2):441-50.e1; quiz 716. PubMed ID: 19109962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assay of trace elements in the serum by the PIXE method in patients with Crohn's disease].
    Deflandre J; Weber G; Delbrouck JM; Roelandts I; Robaye G; Brassinne A
    Gastroenterol Clin Biol; 1985 Oct; 9(10):719-25. PubMed ID: 2998916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An evaluation of the laboratory parameters useful in the determination of disease activity in Crohn disease].
    Puleo A; Cappello M; Orlando A; Dardanoni G; Oliva L; Cottone M
    Recenti Prog Med; 1986 Nov; 77(11):511-4. PubMed ID: 3809704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the concordance between biological markers and clinical activity in inflammatory bowel disease].
    Miranda García P; Chaparro M; Gisbert JP
    Med Clin (Barc); 2015 Jan; 144(1):9-13. PubMed ID: 24530050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.